Free Trial

InMed Pharmaceuticals (INM) SEC Filings & 10K Form

InMed Pharmaceuticals logo
$2.81 +0.11 (+4.07%)
As of 01:51 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Recent InMed Pharmaceuticals SEC Filings

DateFilerForm TypeView
05/16/2025
4:15 PM
InMed Pharmaceuticals (Filer)
Form DEF 14A
05/13/2025
5:19 AM
InMed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/29/2025
7:24 AM
InMed Pharmaceuticals (Filer)
Form PRE 14A
04/02/2025
3:13 PM
AdvisorShares Trust (Filed by)
InMed Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
02/14/2025
1:56 PM
InMed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/13/2025
8:38 AM
InMed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/12/2025
4:30 PM
InMed Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
02/03/2025
10:20 AM
InMed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/03/2025
7:49 AM
HULL ANDREW (Reporting)
InMed Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2025
9:18 AM
InMed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/21/2025
9:54 AM
InMed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/02/2025
10:46 AM
InMed Pharmaceuticals (Filer)
Form 424B3
01/01/2025
11:15 PM
InMed Pharmaceuticals (Filer)
Form EFFECT
12/30/2024
11:16 AM
InMed Pharmaceuticals (Filer)
Form S-1/A
12/23/2024
4:16 PM
InMed Pharmaceuticals (Filer)
Form S-1
Registration statement under Securities Act of 1933  
12/23/2024
8:25 AM
InMed Pharmaceuticals (Issuer)
Lemerond Nicole (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2024
8:26 AM
InMed Pharmaceuticals (Issuer)
Jagpal Netta (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2024
8:28 AM
InMed Pharmaceuticals (Issuer)
Johnson Shane Aaron (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2024
8:17 AM
HULL ANDREW (Reporting)
InMed Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2024
8:18 AM
Baldasare Bryan T (Reporting)
InMed Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2024
8:20 AM
ADAMS ERIC A (Reporting)
InMed Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2024
8:21 AM
HSU ERIC C (Reporting)
InMed Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2024
8:22 AM
Grove Janet P (Reporting)
InMed Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2024
8:24 AM
InMed Pharmaceuticals (Issuer)
WOUDENBERG MICHAEL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2024
5:18 AM
InMed Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
12/19/2024
10:55 AM
InMed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/18/2024
7:05 AM
InMed Pharmaceuticals (Subject)
YA II PN, Ltd. (Filed by)
Form SCHEDULE 13G
11/12/2024
12:44 PM
AdvisorShares Trust (Filed by)
InMed Pharmaceuticals (Subject)
Form SC 13G
11/05/2024
8:08 AM
InMed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/28/2024
3:50 PM
InMed Pharmaceuticals (Filer)
Form DEF 14A
10/28/2024
3:00 PM
InMed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/28/2024
2:25 PM
InMed Pharmaceuticals (Filer)
Form DEFA14A
10/24/2024
2:57 PM
InMed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/23/2024
11:28 AM
InMed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/17/2024
5:30 AM
InMed Pharmaceuticals (Filer)
Form 424B3
09/30/2024
12:37 PM
InMed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/26/2024
3:10 PM
InMed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/21/2024
1:04 PM
InMed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/20/2024
1:00 PM
InMed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/30/2024
2:08 PM
InMed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/27/2024
7:32 PM
InMed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
AI Bloodbath Coming on June 1st? (Ad)

If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new invention… This could send many popular AI stocks crashing, including Nvidia. And it could happen starting as soon as June 1st.

Click here to see the details and learn how to prepare for the next AI revolution
06/11/2024
11:48 AM
InMed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/28/2024
3:26 PM
HSU ERIC C (Reporting)
InMed Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:INM) was last updated on 5/22/2025 by MarketBeat.com Staff
From Our Partners